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Summary
This thesis addresses optimization of radiotherapy of the neck in patients 
with head and neck squamous cell carcinoma (HNSCC) in terms of reducing 
morbidity and improving regional control.
The introduction of intensity modulated radiotherapy (IMRT) created 
markedly more opportunities to optimize radiation dose distribution with 
steeper dose gradients around the target volumes resulting in less dose to 
surrounding healthy tissues. IMRT has been widely adopted for the treatment 
of head and neck cancer, although at that time, comparative studies on patient 
reported xerostomia and health related quality of life were still scarce. We 
tested the hypothesis that reducing the dose to the parotid glands results in 
less patient-rated xerostomia. For this purpose we compared patients treated 
with IMRT and 3D-CRT with regard to radiation-induced xerostomia and 
quality of life (Chapter 2). The results demonstrated a significant reduction of 
the mean parotid gland dose when using IMRT. This ultimately resulted in a 
significant reduction of both patient-rated and observer-rated xerostomia. In 
addition, significantly lower scores were also found for other head and neck 
symptoms. Consequently, the reduction of radiation-induced side effects 
translated into better scores of the more general dimensions of health related 
quality of life.
Patients treated with ipsilateral neck irradiation experience less 
xerostomia than those treated with bilateral neck irradiation. Therefore, 
omitting the contralateral neck from the radiation portals will decrease 
xerostomia rates. In Chapter 3, we investigated prognostic factors for the risk 
of contralateral regional recurrence in HNSCC patients treated with ipsilateral 
neck irradiation in the postoperative setting, to identify patients in whom the 
contralateral neck can be safely omitted from the target volume. We showed 
that in lateralized oral or oropharyngeal carcinomas with a contralateral cN0 
neck, postoperative radiotherapy of the neck can be limited to the ipsilateral 
side. In these patients, the risk of contralateral nodal metastases is very low 
(6%) and in case of a contralateral regional failure, the majority of patients can 
be successfully salvaged. Risk factors for contralateral nodal failure were the 
number of positive nodes in the ipsilateral neck and the presence of extranodal 
spread (borderline significance). The main advantage of omitting contralateral 
elective irradiation is the reduction of late radiation-induced morbidity, 
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especially xerostomia, which ultimately decreased to approximately 5%. 
However, in case of multiple ipsilateral lymph node metastases, particularly in 
the presence of extranodal spread, patients are at risk of occult contralateral 
metastases and should be treated bilaterally.
Chapter 4 investigates outcome and prognostic factors for regional 
recurrence in elective irradiation of the cN0 and pN0 neck, aiming at a better 
selection of subgroups of patients who might be safely treated with ipsilateral 
neck irradiation alone. We showed that in all electively irradiated N0 necks, 
regional control is indeed excellent. In 785 cN0 and pN0 necks, regional control 
at 3 years was 94% in the cN0 (non-dissected) neck compared with 97% in the 
pN0 (dissected) neck.  Prognostic factors associated with a higher rate of neck 
failure are the ipsilateral neck side (compared to contralateral) and positive 
surgical margins, probably due to tumor spill during the surgical procedure. 
Therefore, in case of positive surgical margins of the primary tumor, elective 
nodal irradiation should be applied, even in case of a pN0 neck. Additionally, 
one could argue to withhold elective irradiation to the contralateral pN0 neck 
in case of an ipsilateral pN0 neck. 
In Chapter 5, we described pre-treatment prognostic factors for regional 
recurrence in the N+ neck in a cohort of 3D-CRT treated patients, in order to 
identify patients at risk of regional failure. We showed that nodal volume and 
the addition of chemotherapy are the most important  prognostic factors for 
regional control. Individual nodal control was significantly worse in case of 
larger nodal volumes, no chemotherapy and the presence of extranodal spread 
or central necrosis. Individual nodal control in smaller nodes was generally 
very high, although larger nodes (> 3cm) treated with radiotherapy, with or 
without the addition of chemotherapy showed much lower regional control 
rates. In case of treatment with radiotherapy alone, a minimal dose < 95% of 
the prescribed dose was associated with worse control. In case of combined 
modality treatment, the minimal radiation dose was of less importance.
With 3D-CRT it is sometimes difficult to obtain adequate dose coverage 
of target volumes located in proximity of critical normal structures.  Intensity 
modulated radiotherapy treatment plans can obtain adequate dose coverage 
of target volumes without compromising the tolerance dose to critical 
structures. Therefore, we tested the hypothesis that dose coverage of nodal 
metastases and subsequent nodal control was better in IMRT compared 
to historical 3D-CRT controls (Chapter 6). An important finding was the 
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difference in regional and nodal control among patients treated with 3D-CRT 
compared to IMRT. Nodal and regional control was very high and significantly 
better when IMRT was used, most likely due to improved coverage of the 
nodal gross tumor volume (GTV) in IMRT plans. Nodal volume, minimal nodal 
dose, central necrosis and chemotherapy were identified as independent 
prognostic variables for nodal control. Based on these results, a multivariable 
prediction model for tumor control probability for lymph node metastases 
was developed. This model showed that small  (<1.5 cm) and intermediate (1.5 
– 3.0 cm) sized nodes without central necrosis have excellent control with RT 
alone. Larger nodal volumes, the presence of central necrosis and inadequate 
coverage of the nodal GTV are associated with lower nodal control rates in 
RT alone. The addition of chemotherapy could compensate for these adverse 
prognostic factors. 
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